{"title":"新疆地区首个瘤状皮肤病病毒在牛体内的复制与毒力分析(2019)","authors":"Minmin Zhang, Shaohan Li, Yujie Shi, Xiaolong Xu, Zhiyuan Wen, Jinying Ge, Qiwei Zhang, Xinyin Lu, Xin Yin, Zhigao Bu","doi":"10.1155/tbed/2315442","DOIUrl":null,"url":null,"abstract":"<div>\n <p>Before 2012, lumpy skin disease (LSD) was primarily confined to African countries. However, it rapidly spread to the Middle East and Southeast Europe, reaching the Balkans, the Caucasus, and the Russian Federation by 2015. The first confirmed case in China was reported on August 10, 2019, in Yili, Xinjiang, and on August 26, the Chinese government officially notified the World Organization for Animal Health (WOAH) of the outbreak. In this study, we isolated a LSD virus (LSDV) strain from a severely affected cattle skin sample collected in the Yili region of Xinjiang and designated it as strain Xinjiang/2019. Next-generation sequencing (NGS) analysis revealed that strain Xinjiang/2019 shared the highest similarity with the LSDV/Russia/Saratov/2017 strain based on full-length LSDV sequences available in NCBI. Phylogenetic analysis revealed that the Xinjiang/2019 isolate clustered with strains from China, Vietnam, Thailand, and Indonesia, forming a distinct phylogenetic branch. Recombination analysis further indicated that Xinjiang/2019 is predominantly a recombinant strain, derived from South African and European strains. To assess pathogenicity, cattle were infected with strain Xinjiang/2019 via intravenous (Group I) or intradermal (Group II) injection. In Group I, four out of five animals developed typical LSD symptoms, including fever (day 7), secondary nodules (day 8), rhinitis, conjunctivitis, and lymph node enlargement. Group II showed viremia by day 5 with milder symptoms. These findings indicate that strain Xinjiang/2019 is a virulent strain responsible for the first LSD outbreak in China.</p>\n </div>","PeriodicalId":234,"journal":{"name":"Transboundary and Emerging Diseases","volume":"2025 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbed/2315442","citationCount":"0","resultStr":"{\"title\":\"Replication and Virulence in Cattle of the First Lumpy Skin Disease Virus Isolated in Xinjiang, China (2019)\",\"authors\":\"Minmin Zhang, Shaohan Li, Yujie Shi, Xiaolong Xu, Zhiyuan Wen, Jinying Ge, Qiwei Zhang, Xinyin Lu, Xin Yin, Zhigao Bu\",\"doi\":\"10.1155/tbed/2315442\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n <p>Before 2012, lumpy skin disease (LSD) was primarily confined to African countries. However, it rapidly spread to the Middle East and Southeast Europe, reaching the Balkans, the Caucasus, and the Russian Federation by 2015. The first confirmed case in China was reported on August 10, 2019, in Yili, Xinjiang, and on August 26, the Chinese government officially notified the World Organization for Animal Health (WOAH) of the outbreak. In this study, we isolated a LSD virus (LSDV) strain from a severely affected cattle skin sample collected in the Yili region of Xinjiang and designated it as strain Xinjiang/2019. Next-generation sequencing (NGS) analysis revealed that strain Xinjiang/2019 shared the highest similarity with the LSDV/Russia/Saratov/2017 strain based on full-length LSDV sequences available in NCBI. Phylogenetic analysis revealed that the Xinjiang/2019 isolate clustered with strains from China, Vietnam, Thailand, and Indonesia, forming a distinct phylogenetic branch. Recombination analysis further indicated that Xinjiang/2019 is predominantly a recombinant strain, derived from South African and European strains. To assess pathogenicity, cattle were infected with strain Xinjiang/2019 via intravenous (Group I) or intradermal (Group II) injection. In Group I, four out of five animals developed typical LSD symptoms, including fever (day 7), secondary nodules (day 8), rhinitis, conjunctivitis, and lymph node enlargement. Group II showed viremia by day 5 with milder symptoms. These findings indicate that strain Xinjiang/2019 is a virulent strain responsible for the first LSD outbreak in China.</p>\\n </div>\",\"PeriodicalId\":234,\"journal\":{\"name\":\"Transboundary and Emerging Diseases\",\"volume\":\"2025 1\",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbed/2315442\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transboundary and Emerging Diseases\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1155/tbed/2315442\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transboundary and Emerging Diseases","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/tbed/2315442","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Replication and Virulence in Cattle of the First Lumpy Skin Disease Virus Isolated in Xinjiang, China (2019)
Before 2012, lumpy skin disease (LSD) was primarily confined to African countries. However, it rapidly spread to the Middle East and Southeast Europe, reaching the Balkans, the Caucasus, and the Russian Federation by 2015. The first confirmed case in China was reported on August 10, 2019, in Yili, Xinjiang, and on August 26, the Chinese government officially notified the World Organization for Animal Health (WOAH) of the outbreak. In this study, we isolated a LSD virus (LSDV) strain from a severely affected cattle skin sample collected in the Yili region of Xinjiang and designated it as strain Xinjiang/2019. Next-generation sequencing (NGS) analysis revealed that strain Xinjiang/2019 shared the highest similarity with the LSDV/Russia/Saratov/2017 strain based on full-length LSDV sequences available in NCBI. Phylogenetic analysis revealed that the Xinjiang/2019 isolate clustered with strains from China, Vietnam, Thailand, and Indonesia, forming a distinct phylogenetic branch. Recombination analysis further indicated that Xinjiang/2019 is predominantly a recombinant strain, derived from South African and European strains. To assess pathogenicity, cattle were infected with strain Xinjiang/2019 via intravenous (Group I) or intradermal (Group II) injection. In Group I, four out of five animals developed typical LSD symptoms, including fever (day 7), secondary nodules (day 8), rhinitis, conjunctivitis, and lymph node enlargement. Group II showed viremia by day 5 with milder symptoms. These findings indicate that strain Xinjiang/2019 is a virulent strain responsible for the first LSD outbreak in China.
期刊介绍:
Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):
Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.
Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.
Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.
Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).
Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.